|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Imaging |
Departments of Neurology and Neurosurgery (M.A.B., H.G.J.K.), Radiology (S.D.R., K.M.S.), and Biophysics (K.J.R., A.P.P., K.M.S.), Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
3 Address correspondence to Kathleen M. Schmainda, Medical College of Wisconsin, Department of Biophysics, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA (kathleen{at}mcw.edu).
Abstract
Depending on dose, dexamethasone has been shown to inhibit or stimulate growth of rat 9L gliosarcoma and decrease the expression of vascular endothelial growth factor (VEGF), an important mediator of tumor-associated angiogenesis. We demonstrate, by constructing relative cerebral blood volume (rCBV) maps with MRI, that dexamethasone also decreases total blood volume while increasing microvascular blood volume in Fischer rats bearing intracranial 9L gliosarcoma. Animals were inoculated with 1 x 105 9L gliosarcoma tumor cells. On days 10-14 after tumor cell inoculation, animals were intraperitoneally injected with dexamethasone (3 mg/kg) over 5 days. MRI-derived gradient echo (GE) and spin-echo (SE) rCBV maps were created to demonstrate total vasculature (GE) and microvasculature (SE). After MRI studies were performed, the rat's vasculature was perfused with a latex compound. Total vessel volume and diameters were assessed by microscopy. Dexamethasone decreased the tumor-enhancing area of postcontrast T1-weighted images (P < 0.0001) and total tumor volume (P = 0.0085). In addition, there was a greater than 50% decrease in GE rCBV (total vasculature) (P = 0.007) as well as a significant decrease in total fractional blood volume, as validated by histology (P = 0.0007). Conversely, there was an increase in SE rCBV signal (microvasculature) in animals treated with dexamethasone (P = 0.05), which was consistent with microscopy (P < 0.0001). These data demonstrate that (1) dexamethasone selectively treats tumor vasculature, suggesting a vessel-size selective effect and (2) MRI-derived rCBV is a noninvasive technique that can be used to evaluate changes in blood volume and vascular morphology.
References
Aronen, H.J., Gazit, I.E., Louis, D.N., Buchbinder, B.R., Pardo,
F.S., Weisskoff, R.M., Harsh, G.R., Cosgrove, G.R., Halpern, E.F., Hochberg,
F.H., and Rosen, B.R. (1994) Cerebral blood volume maps of
gliomas: Comparison with tumor grade and histologic findings.
Radiology 191,41
-51.
Aronen, H.J., Pardo, F.S., Kennedy, D.N., Belliveau, J.W., Packard,
S.D., Hsu, D.W., Hochberg, F.H., Fischman, A.J., and Rosen, B.R.
(2000) High microvascular blood volume is associated with high
glucose uptake and tumor angiogenesis in human gliomas. Clin.
Cancer Res. 6,2189
-2200.
Arrieta, O., Guevara, P., Reyes, S., Ortiz, A., Rembao, D., and Sotelo, J. (1998) Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine. Eur. J. Cancer 34,2101 -2106.
Badruddoja, M.A., Krouwer, H.G., Schmainda, K.G., Rand, S.D., Rebro, K.J., Pathak, A.P., and Marszalkowski, C.S. (2001) Dexamethasone decreases relative cerebral blood volume (rCBV) and vessel diameter in 9L gliosarcoma. Neuro-Oncol. 3, 266. (Abstract 1)
Bernsen, H.J., and van der Kogel, A.J. (1999) Antiangiogenic therapy in brain tumor models. J. Neurooncol. 45,247 -255.[CrossRef][Medline]
Bernsen, H.J., Rijken, P.F., Peters, H., Bakker, H., and van der Kogel, A.J. (1998) The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice. J. Neurooncol. 38, 51-57.[CrossRef][Medline]
Boxerman, J.L., Hamberg, L.M., Rosen, B.R., and Weisskoff, R.M. (1995) MR contrast due to intravascular magnetic susceptibility perturbations. Magn. Reson. Med. 34,555 -566.[ISI][Medline]
Bruening, R., Kwong, K.K., Vevea, M.J., Hochberg, F.H., Cher, L., Harsh, G.R. 4th, Niemi, P.T., Weisskoff, R.M., and Rosen, B.R. (1996) Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. Am. J. Neuroradiol. 17,831 -840.[Abstract]
Deane, B.R., and Lantos, P.L. (1981) The vasculature of experimental brain tumors. Part 2. A quantitative assessment of morphological abnormalities. J. Neurol. Sci. 49, 67-77.[CrossRef][ISI][Medline]
Dempke, W., Rie, C., Grothey, A., and Schmoll, H.J. (2001) Cyclooxygenase-2: A novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol. 127,411 -417.[CrossRef][ISI][Medline]
Dewhirst, M.W., Tso, C.Y., Oliver, R., Gustafson, C.S., Secomb, T.W., and Gross, J.F. (1989) Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int. J. Radiat. Oncol. Biol. Physiol. 17, 91-99.[ISI][Medline]
Donahue, K.M., Krouwer, H.G., Rand, S.D., Pathak, A.P., Marszalkowski, C.S., Censky, S.C., and Prost, R.W. (2000) Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn. Reson. Med. 43,845 -853.[CrossRef][ISI][Medline]
Farrell, C.L., Stewart, P.A., Farrell, C.R., Del Maestro, R.F., and Coomber, B.L. (1991) The effect of cellular microenvironment on vessels in the brain. Part II: Vessel function and structure in a rat glioma (In Proceedings of 16th L.H. Gray Confrence). Int. J. Radiat. Biol. 60,138 .
Fisel, C.R., Ackerman, J.L., Buxton, R.B., Garrido, L., Belliveau, J.W., Rosen, B.R., and Brady, T.J. (1991) MR contrast due to microscopically heterogeneous magnetic susceptibility: Numerical simulations and applications to cerebral physiology. Magn. Reson. Med. 17,336 -347.[ISI][Medline]
Folkman, J., and Ingber, D.E. (1987) Angiostatic steroids. Method of discovery and mechanism of action. Ann. Surg. 206,374 -383.[CrossRef][ISI][Medline]
Folkman, J., Langer, R., Linhardt, R.J., Haudenschild, C., and
Taylor, S. (1983) Angiogenesis inhibition and tumor regression
caused by heparin or a heparin fragment in the presence of cortisone.
Science 221,719
-725.
Gale, N.W., and Yancopoulos, G.D. (1999) Growth
factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs,
angiopoietins, and ephrins in vascular development. Genes
Dev. 13,1055
-1066.
Gossmann, A., Helbich, T.H., Kuriyama, N., Ostrowitzki, S., Roberts, T.P., Shames, D.M., vanBruggen, N., Wendland, M.F., Israel, M.A., and Brasch, R.C. (2002) Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J. Magn. Reson. Imaging 15,233 -240.[CrossRef][ISI][Medline]
Heiss, J.D., Papavassiliou, E., Merrill, M.J., Nieman, L., Knightly, J.J., Walbridge, S., Edwards, N.A., and Oldfield, E.H. (1996) Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J. Clin. Invest. 98,1400 -1408.[ISI][Medline]
Holash, J., Maisonpierre, P.C., Compton, D., Boland, P., Alexander,
C.R., Zagzag, D., Yancopoulos, G.D., and Wiegand, S.J. (1999)
Vessel cooption, regression, and growth in tumors mediated by angiopoietins
and VEGF. Science 284,1994
-1998.
ILAR. Institute of Laboratory Animal Resources, National Research Council (1996) Guide for the Care and Use of Laboratory Animals. Washington, D.C.: National Academy Press.
Leenders, K.L., Beaney, R.P., Brooks, D.J., Lammertsma, A.A.,
Heather, J.D., and McKenzie, C.G. (1985) Dexamethasone treatment
of brain tumor patients: Effects on regional cerebral blood flow, blood
volume, and oxygen utilization. Neurology
35,1610
-1616.
Machein, M.R., and Plate, K.H. (2000) VEGF in brain tumors. J. Neurooncol. 50,109 -120.[CrossRef][Medline]
Machein, M.R., Kullmer, J., Ronicke, V., Machein, U., Krieg, M., Damert, A., Breier, G., Risau, W., and Plate, K.H. (1999) Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol. Appl. Neurobiol. 25,104 -112.[CrossRef][ISI][Medline]
Maeda, M., Itoh, S., Kimura, H., Iwasaki, T., Hayashi, N.,
Yamamoto, K., Ishii, Y., and Kubota, T. (1993) Tumor vascularity
in the brain: Evaluation with dynamic susceptibility-contrast MR imaging.
Radiology 189,233
-238.
Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand,
S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos,
N., Daly, T.J., Davis, S., Sato, T.N., and Yancopoulos, G.D.
(1997) Angiopoietin-2, a natural antagonist for Tie2 that
disrupts in vivo angiogenesis. Science
277, 55-60.
Majumdar, S., Zoghbi, S., and Gore, J.C. (1989) The influence of pulse sequence on the relaxation effects of superparamagnetic iron oxide contrast agents. Magn. Reson. Med. 10,289 -301.[ISI][Medline]
O'Reilly, M.S., Holmgren, L., Shing,Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H., and Folkman, J. (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79,315 -328.[CrossRef][ISI][Medline]
O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R., and Folkman, J. (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88,277 -285.[CrossRef][ISI][Medline]
Ostergaard, L., Hochberg, F.H., Rabinov, J.D., Sorensen, A.G., Lev, M., Kim, L., Weisskoff, R.M., Gonzalez, R.G., Gyldensted, C., and Rosen, B.R. (1999) Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J. Neurosurg. 90,300 -305.[ISI][Medline]
Pathak, A.P., Schmainda, K.M., Ward, B.D., Linderman, J.R., Rebro, K.J., and Greene, A.S. (2001) MR-derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis. Magn. Reson. Med. 46,735 -747.[CrossRef][ISI][Medline]
Pathak, A.P., Rand, S.D., and Schmainda, K.M. (2003) The effect of brain tumor angiogenesis on the in vivo relationship between the gradient echo relaxation rate change (DR2*) and contrast agent (MION) dose. J. Magn. Reson. Imaging (in press).
Plate, K.H., Breier, G., Millauer, B., Ullrich, A., and Risau, W.
(1993) Upregulation of vascular endothelial growth factor and its
cognate receptors in a rat glioma model of tumor angiogenesis.
Cancer Res. 53,5822
-5827.
Rand, S.D., Schmainda, K.M., Pathak, A.P., Badruddoja, M.A., Rebro, K.J., and Krouwer, H.G.J. (2002) Effects of dexamethasone on rat 9L gliosarcoma model vasculature measured with MR derived relative cerebral blood volume maps and validated with histologic analysis. Presented at 40th Annual Meeting, American Society of Neuroradiology, Vancouver, B.C., Canada, May 13-17.
Rieder, M.J., O'Drobinak, D.M., and Greene, A.S. (1995) A computerized method for determination of microvascular density. Microvasc. Res. 49,180 -189.[CrossRef][ISI][Medline]
Schmainda (Donahue), K.M., Pathak, A.P., Badruddoja, M., Rand, S.D., Rebro, K., and Krouwer, H.G. (2001) Effect of dexamethasone treatment on dynamic susceptibility CBV measurements in a rat brain tumor model. Presented at Ninth Annual Meeting, International Society for Magnetic Resonance in Medicine, Glasgow, Scotland, April 21-27.
Schmainda, K.M., Rand, S.D., Badruddoja, M., Pathak, A.P., Rebro, K.J., and Krouwer, H.G. (2002a) Dexamethasone selectively treats tumor vasculature as demonstrated by simultaneous GE and SE rCBV measurements. Presented at Tenth Annual Meeting, International Society for Magnetic Resonance in Medicine, Honolulu, Hawaii, U.S.A., May 18-24.
Schmainda, K.M., Rand, S.D., Joseph, A.M., Hanson, R., Ward, B.D., Pathak, A.P., Badruddoja, M.A., and Krouwer, H.G.J. (2002b)Dynamic GE and SE measurements of tumor blood volume and vascular morphology predict tumor grade in patients with brain tumors . Presented at International Society for Magnetic Resonance in Medicine Workshop on In Vivo Functional and Molecular Assessment of Cancer, Santa Cruz, Calif., U.S.A., October 19-21.
Shoshan, Y., and Siegal, T. (1996) Control of vasogenic edema in a brain tumor model: Comparison between dexamethasone and superoxide dismutase. Neurosurgery 39,1206 -1214.[CrossRef][ISI][Medline]
Sugahara, T., Korogi, Y., Kochi, M., Ushio, Y., and Takahashi, M.
(2001) Perfusion-sensitive MR imaging of gliomas: Comparison
between gradient-echo and spin-echo echo-planar imaging techniques.
Am. J. Neuroradiol. 22,1306
-1315.
Wolff, J.E., Guerin, C., Laterra, J., Bressler, J., Indurti, R.R., Brem, H., and Goldstein, G.W. (1993) Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Res. 604,79 -85.[CrossRef][ISI][Medline]
Zama, A., Tamura, M., and Inoue, H.K. (1991) Three-dimensional observations on microvascular growth in rat glioma using a vascular casting method. J. Cancer Res. Clin. Oncol. 117,396 -402.[CrossRef][ISI][Medline]
This article has been cited by other articles:
|
|
 |
|
  Y. R. Kim, A. Yudina, J. Figueiredo, W. Reichardt, D. Hu-Lowe, A. Petrovsky, H. W. Kang, D. Torres, U. Mahmood, R. Weissleder, et al. Detection of Early Antiangiogenic Effects in Human Colon Adenocarcinoma Xenografts: In vivo Changes of Tumor Blood Volume in Response to Experimental VEGFR Tyrosine Kinase Inhibitor Cancer Res., October 15, 2005; 65(20): 9253 - 9260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. M. Maia Jr, S. M. F. Malheiros, A. J. da Rocha, C. J. da Silva, A. A. Gabbai, F. A. P. Ferraz, and J. N. Stavale MR Cerebral Blood Volume Maps Correlated with Vascular Endothelial Growth Factor Expression and Tumor Grade in Nonenhancing Gliomas AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 777 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Covarrubias, B. R. Rosen, and M. H. Lev Dynamic Magnetic Resonance Perfusion Imaging of Brain Tumors Oncologist, September 1, 2004; 9(5): 528 - 537. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
